Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?

Abstract excerpt

In vitro studies of HBV core promoter mutations in hepatoma cell lines suggest that some mutations in core promoter transcription factor binding sites result in reduced core promoter activity and viral replication. We sought to validate this hypothesis using clinical samples with viral load differences before and after HBeAg seroconversion. A consensus sequence for transcription factor binding sites/regulatory...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Consensus Sequence
• Share to DNA, Viral